| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands
Address correspondence and reprint requests to Gerard F. A. Jansen, MD, Department of Anesthesiology, H-1-Z, Academic Medical Centre, University of Amsterdam, P.O. Box 22600, 1100 DE Amsterdam, The Netherlands.
| Abstract |
|---|
|
|
|---|
Implications: During propofol anesthesia at normoventilation, 50% of brain tumor patients showed signs suggesting cerebral hypoperfusion, but this could not be demonstrated during isoflurane/nitrous oxide anesthesia. During PaCO2 manipulations, consecutive measurements of the cerebral blood flow velocity may be inadequate to assess cerebral oxygenation.
| Introduction |
|---|
|
|
|---|
Studies have shown that, although isoflurane reduces CMRO2 dose-dependently, it maintains or increases CBF (5,6). In addition, several authors have reported that the CBF is greater when nitrous oxide is added to isoflurane (7,8), but this produces no effects on CMR (9). This suggests that nitrous oxide produces cerebral vasodilation, which is unopposed by CMR-mediated vasoconstriction. Thus, isoflurane/nitrous oxide anesthesia maintains or increases CBF and reduces CMR, thereby possibly producing an increase of the CBF/CMR ratio.
In contrast, propofol has been reported to reduce CBF in humans (3,4,10). Several studies demonstrated that the reduction of CBF was larger than the reduction of CMRO2, which suggests that propofol may have direct cerebral vasoconstricting activity (3,11,12), which might lead to a decrease of cerebral perfusion and a decrease of the CBF/CMR ratio. The hypothesis of this study was that, during propofol anesthesia, the brain is relatively hypoperfused compared with isoflurane/nitrous oxide anesthesia, resulting in a decreased brain oxygen supply and demand ratio. Accordingly, the purpose of our study was to determine the jugular bulb venous blood oxygen saturation (SjO2) as a measure of the flow metabolism ratio during normoventilation and hyperventilation under propofol or isoflurane/nitrous oxide anesthesia in patients with intracranial mass lesions. Middle cerebral artery blood flow velocity (Vmca), measured by using transcranial Doppler sonography, was used to correlate the changes of SjO2.
| Methods |
|---|
|
|
|---|
The arterial to jugular bulb venous oxygen content differences (AJDO2) were calculated from the arterial and jugular bulb venous oxygen partial pressure and saturation using the equation:
|
|
|
|
|
|
|
|
|
|
Because CMRO2 is not influenced by hyperventilation during steady-state anesthesia, any change in cerebral oxygen consumption is considered to be reciprocally related to the change in CBF; thus, changes in 1/AJDO2 will reflect changes in CBF. Because we assumed that, on hyperventilation, the relative changes of Vmca parallel relative changes of CBF, the relationship between the relative change of Vmca on the T side and the NT side, and the relative change of 1/AJDO2 was accordingly subjected to linear correlation analysis using Pearsons correlation coefficient.
Comparisons between values were assessed by using analysis of variance. When significance was found, a post hoc test (Bonferroni-Dunn) was performed to delineate where differences lay. A P value <0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
Vmca on the T side, as well as on the NT side, was not significantly different between Group 1 and Group 2 in the awake state (Table 1) and during anesthesia at normoventilation and at hyperventilation (Table 2). The relative decrease of Vmca on the T side and NT side during anesthesia on hyperventilation was not significantly different between the two groups. There was no correlation between the relative decreases of Vmca on the T side and the NT side and the relative decrease of 1/AJDO2 (r = 0.21, P = 0.41, n = 38) (Fig. 2).
|
| Discussion |
|---|
|
|
|---|
In awake healthy humans, SjO2 ranges between 55% and 75% (mean 62%) (13). SjO2 reflects the balance between brain oxygen supply and demand and indicates whether CBF is sufficient to satisfy the oxygen demands of the brain tissues. Values of SjO2 <50% indicate cerebral hypoperfusion, and readings <40% are associated with global cerebral ischemia (14,15). In our study, half of the patients under propofol anesthesia showed SjO2 <50%, compatible with relative cerebral hypoperfusion, and three of these patients showed SjO2 <40% and AJDO2 >9 mL/dL, compatible with cerebral ischemia. None of the patients had SjO2 <50% during isoflurane/nitrous oxide anesthesia. SjO2 monitoring provides a global cerebral measurement. However, regional ischemia cannot be detected. Thus, the normal SjO2 in the patients under isoflurane/nitrous oxide anesthesia does not indicate the absence of regional ischemia, but the low SjO2 in three patients in the propofol group may be indicative of global ischemia, focal ischemia, or both.
Several studies have reported SjO2 values >50% in patients with intracranial pathology undergoing craniotomy during anesthesia with 0.5%1% isoflurane in nitrous oxide/oxygen or air/oxygen at a mean PaCO2 of 30 mm Hg (16,17). In our study, SjO2 was 60% ± 6% at a PaCO2 of 35 ± 2 mm Hg during isoflurane/nitrous oxide anesthesia, and all patients had SjO2 >50%. Stephan et al. (3) found SjO2 of 41% at a mean PaCO2 of 30 mm Hg in patients during propofol anesthesia who received multiple cardiac drug therapy. Another study showed SjO2 of 60% in patients undergoing cerebral aneurysm surgery under propofol anesthesia at PaCO2 values of 2634 mm Hg; 23% of these had SjO2 <50% (18). In our study, SjO2 was 49% in the patients under propofol anesthesia at a mean PaCO2 of 33 mm Hg. The results of our study are in agreement with data from previous studies (3,1618) and demonstrate that SjO2 during propofol anesthesia is lower than that during isoflurane/nitrous oxide anesthesia. One explanation for the lower SjO2 in the propofol group is an imbalance between the oxygen demand of the brain and CBF, with CBF being inadequate to supply oxygen to the brain. Stephan et al. (3) showed a decrease of CBF of 54% and a reduction of CMRO2 of 33% after the induction of propofol anesthesia. Vandesteene et al. (4) also showed a significant decrease of CBF by 28% (P < 0.02) and an insignificant decrease of CMRO2 during propofol anesthesia. Van Hemelrijck et al. (11) found that propofol anesthesia reduced CBF by 40% but failed to find any concomitant decrease in CMRO2. In contrast, CBF was maintained at low isoflurane concentrations and was increased with higher isoflurane concentrations (5,6).
The CBF changes observed with propofol and isoflurane/nitrous oxide are the net result of two interactions. First, because these drugs depress CMRO2, they produce an indirect decrease of CBF if coupling between CMRO2 and CBF is preserved. Second, they produce either direct vasoconstriction or vasodilation of the cerebral vessels. An explanation for the decrease of CBF during propofol could be attributed to a direct vasoconstricting effect on cerebral vessels. However, direct vasoconstricting effects of propofol on cerebral arteries in animals in vitro have not been demonstrated (19,20). In those in vitro studies, only the larger basal arteries (the capacitance vessels) were investigated, but the smaller cerebral arterioles (the resistance vessels) were not examined. An alternative explanation for a decrease of CBF in our patients when propofol was administered is that the lower limit of the CBF autoregulation was shifted to the right and that CBF was pressure-dependent at the measured MAP values. For example, Moss et al. (18) observed that the increase in MAP with IV phenylephrine improved SjO2 to values >54% in eight of nine patients who had SjO2 <54% during subarachnoid hemorrhage surgery under propofol anesthesia. They defined a critical MAP, which was attained with phenylephrine, and which was between 80 and 110 mm Hg in their patients, as the MAP that resulted in SjO2 improvement >54%. This increase in SjO2 with increasing MAP could be the result of either a defective autoregulation after subarachnoid hemorrhage or an increase of the lower limit of autoregulation under propofol anesthesia (11). In our study, the five patients with SjO2 <50% had MAP values between 69 and 110 mm Hg. Thus, MAP values under the critical MAP as a cause for the SjO2 <50% in these five patients could not be excluded. However, in our patients receiving isoflurane/nitrous oxide anesthesia, signs of a critical MAP could not be demonstrated because all patients had SjO2 >50%.
In Group 2, SjO2 increased in two patients in response to hyperventilation from 50% to 59%, and from 34% to 43%, despite a relatively constant PjO2 (2927 mm Hg and 2222 mm Hg) (Fig. 1). Because P50 is not influenced during propofol or isoflurane anesthesia, we suggest that these increases in SjO2 are compatible with a leftward shift of the oxygen dissociation curve in relation to hyperventilation (Bohr effect) (21), yielding decreases of jugular bulb venous PCO2 of 14 and 13 mm Hg and arterial pH values of 7.69 and 7.59. Data from these two patients demonstrate that continuous monitoring of SjO2 to assess the brain oxygenation on hyperventilation might give the wrong impression of an improvement in brain oxygenation. Determination of PjO2 is probably a more reliable monitor of oxygenation of the brain.
TCD is a noninvasive means by which to measure red blood cell velocity. Although TCD does not provide a direct measure of CBF, relative changes of Vmca accurately reflect relative changes of CBF, provided the diameter of the insonated vessel remains unchanged (22,23). Studies have shown that the diameter of the MCA does not change significantly with changes of PaCO2 or with the systemic administration of phenylephrine (2426). Matta et al. (24) showed, in healthy patients during pharmacologically induced isoelectric electroencephalogram, that the addition of inhaled anesthetics produced an increase of Vmca that closely correlates with the increase of 1/AJDO2 (1/AJDO2 being an equivalent of CBF). However, in our study, there was no correlation between the relative changes of Vmca and 1/AJDO2 on hyperventilation (Fig. 2). A similar lack of correlation has been reported in other studies (10,27,28). For example, in subjects who underwent cerebrovascular reactivity tests for a variety of types of intracranial lesions, Brauer et al. (27) found no correlation between changes of CBF and Vmca. During isoflurane/nitrous oxide anesthesia, Shah et al. (28) found the CBF response to CO2 to be unpredictable in subjects with edematous brain tumors. In patients with a brain tumor, Schregel et al. (10) showed reduced or even paradoxical effects of propofol and hyperventilation on Vmca. The results of our study show that, on hyperventilation in brain tumor patients, the adequacy of cerebral oxygenation cannot be obtained from consecutive Vmca measurements alone, and shifts in Vmca as an indication of CBF changes should be interpreted with caution in patients with brain tumors.
In conclusion, brain tumor patients under propofol anesthesia, even at clinically accepted PaCO2 levels, showed SjO2 and PjO2 levels that were significantly lower than those in patients under isoflurane-nitrous oxide anesthesia. In these patients, consecutive Vmca measurements were inadequate to assess the cerebral oxygenation during PaCO2 manipulations.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. W. Gelb, R. A. Craen, G. S. U. Rao, K. R. M. Reddy, J. Megyesi, B. Mohanty, H. H. Dash, K. C. Choi, and M. T. V. Chan Does Hyperventilation Improve Operating Condition During Supratentorial Craniotomy? A Multicenter Randomized Crossover Trial Anesth. Analg., February 1, 2008; 106(2): 585 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Conti, D. G. Iacopino, V. Fodale, S. Micalizzi, O. Penna, and L. B. Santamaria Cerebral haemodynamic changes during propofol-remifentanil or sevoflurane anaesthesia: transcranial Doppler study under bispectral index monitoring Br. J. Anaesth., September 1, 2006; 97(3): 333 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rasmussen, R. N. Upton, C. Grant, A. M. Martinez, G. E. Cold, and G. Ludbrook The effects of indomethacin on intracranial pressure and cerebral hemodynamics during isoflurane or propofol anesthesia in sheep with intracranial hypertension. Anesth. Analg., June 1, 2006; 102(6): 1823 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Diephuis, K. G. M. Moons, A. N. Nierich, M. Bruens, D. van Dijk, and C. J. Kalkman Jugular bulb desaturation during coronary artery surgery: a comparison of off-pump and on-pump procedures Br. J. Anaesth., June 1, 2005; 94(6): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshitani, M. Kawaguchi, M. Iwata, N. Sasaoka, S. Inoue, N. Kurumatani, and H. Furuya Comparison of changes in jugular venous bulb oxygen saturation and cerebral oxygen saturation during variations of haemoglobin concentration under propofol and sevoflurane anaesthesia Br. J. Anaesth., March 1, 2005; 94(3): 341 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yoshitani, M. Kawaguchi, K. Tatsumi, N. Sasaoka, N. Kurumatani, and H. Furuya Intravenous Administration of Flurbiprofen Does Not Affect Cerebral Blood Flow Velocity and Cerebral Oxygenation Under Isoflurane and Propofol Anesthesia Anesth. Analg., February 1, 2004; 98(2): 471 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Johnston, L. A. Steiner, D. A. Chatfield, M. R. Coleman, J. P. Coles, P. G. Al-Rawi, D. K. Menon, and A. K. Gupta Effects of propofol on cerebral oxygenation and metabolism after head injury Br. J. Anaesth., December 1, 2003; 91(6): 781 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Iwata, S. Inoue, M. Kawaguchi, M. Takahashi, T. Sakamoto, K. Kitaguchi, H. Furuya, and T. Sakaki Comparison of the effects of sevoflurane and propofol on cooling and rewarming during deliberate mild hypothermia for neurosurgery Br. J. Anaesth., January 1, 2003; 90(1): 32 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaffranietz, C. Rudolph, W. Heinke, H. R. Munoz, and J. E. De la Fuente Propofol, Nitrous Oxide, and Jugular Bulb Oxygen Saturation * Response Anesth. Analg., November 1, 2002; 95(5): 1459 - 1460. [Full Text] [PDF] |
||||
![]() |
A. Cenic, R. A. Craen, T.-Y. Lee, and A. W. Gelb Cerebral Blood Volume and Blood Flow Responses to Hyperventilation in Brain Tumors During Isoflurane or Propofol Anesthesia Anesth. Analg., March 1, 2002; 94(3): 661 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Munoz, G. E. Nunez, J. E. de la Fuente, and M. G. Campos The Effect of Nitrous Oxide on Jugular Bulb Oxygen Saturation During Remifentanil Plus Target-Controlled Infusion Propofol or Sevoflurane in Patients with Brain Tumors Anesth. Analg., February 1, 2002; 94(2): 389 - 392. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saito, Y. Kadoi, T. Nara, M. Sudo, H. Obata, T. Morita, and F. Goto The Comparative Effects of Propofol Versus Thiopental on Middle Cerebral Artery Blood Flow Velocity During Electroconvulsive Therapy Anesth. Analg., December 1, 2000; 91(6): 1531 - 1536. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Olive, M. Noguer, G. F. A. Jansen, M. B. Kedaria, J. A. Odoom, and B. H. van Praagh Global Cerebral Hypoperfusion and PaCO2 Response Anesth. Analg., April 1, 2000; 91(1): 246 - 246. [Full Text] [PDF] |
||||
![]() |
C. De Deyne, R. De Jongh, R. Heylen, M. Struys, G. Jansen, M. Kedaria, J. Odoom, and B. van Praagh Jugular Bulb Desaturations During Propofol Anesthesia in Neurosurgical Procedures • Response Anesth. Analg., March 1, 2000; 90(3): 769 - 769. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|